DEAR MAYO CLINIC: I'm a 50-year-old woman recently diagnosed with scleroderma. What causes it, and can anything stop its progression? What medications are available, and at what point should I begin ...

UVA researcher Blandine Baffert, working in the lab of UVA Health’s Sanja Arandjelovic and collaborating with researchers in ...

Please provide your email address to receive an email when new articles are posted on . BLR-200 has yielded “promising” results in ongoing research. The therapy targets multiple drivers of scleroderma ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Scientists at the University of Virginia say they may be one step closer to stopping a rare and deadly disease that hardens ...

Mycophenolate mofetil shows similar disease control to methotrexate in children with juvenile localized scleroderma, with ...

The prognosis for patients diagnosed with scleroderma - an autoimmune disease characterized by fibrosis of the skin - is not typically a rosy one. With limited treatment options available, those ...

The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com’s ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other ...

PHILADELPHIA (WPVI) -- When a rare disease strikes, getting a diagnosis can take years, enabling the disease to progress. A young woman from the Mayfair section of Philadelphia details her battle to ...

The "US Scleroderma Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. US Scleroderma Market and Competitive Landscape Highlights – 2021, provides ...